We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.93B
AUM Growth
+$244M
Cap. Flow
+$17M
Cap. Flow %
0.43%
Top 10 Hldgs %
14.31%
Holding
1,432
New
108
Increased
538
Reduced
575
Closed
84

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$7.62M
2
BABA icon
Alibaba
BABA
+$7.25M
3
TDOC icon
Teladoc Health
TDOC
+$4.82M
4
TSN icon
Tyson Foods
TSN
+$4.64M
5
QCOM icon
Qualcomm
QCOM
+$3.85M

Sector Composition

Rank Sector Weight
1 Technology 13.34%
2 Healthcare 12.65%
3 Financials 11.21%
4 Industrials 9.34%
5 Consumer Discretionary 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BVN icon
251
Compañía de Minas Buenaventura
BVN
$8.09B
$3.55M 0.09%
264,817
+11,175
+4% +$145K
VRNT
252
DELISTED
Verint Systems
VRNT
$3.55M 0.09%
139,026
+12,138
+10% +$295K
NKE icon
253
Nike
NKE
$62.7B
$3.54M 0.09%
41,761
+1,081
+3% +$86.8K
PLNT icon
254
Planet Fitness
PLNT
$4.43B
$3.51M 0.09%
65,000
RIO icon
255
Rio Tinto
RIO
$158B
$3.5M 0.09%
68,680
+4,565
+7% +$233K
MKC icon
256
McCormick & Company Non-Voting
MKC
$13.7B
$3.5M 0.09%
53,140
-17,988
-25% -$1.11M
J icon
257
Jacobs Solutions
J
$15.7B
$3.49M 0.09%
55,180
+333
+0.6% +$19.5K
AMLP icon
258
Alerian MLP ETF
AMLP
$12.9B
$3.49M 0.09%
65,303
-26,998
-29% -$1.46M
CI icon
259
Cigna
CI
$76.1B
$3.46M 0.09%
16,591
+3,129
+23% +$580K
TYG
260
Tortoise Energy Infrastructure Corp
TYG
$1.09B
$3.4M 0.09%
31,571
-308
-1% -$34.5K
VGK icon
261
Vanguard FTSE Europe ETF
VGK
$30.8B
$3.4M 0.09%
60,498
-1,949
-3% -$110K
FE icon
262
FirstEnergy
FE
$28.2B
$3.39M 0.09%
91,169
-1,698
-2% -$62K
GM icon
263
General Motors
GM
$80B
$3.39M 0.09%
100,591
+2,035
+2% +$75K
EL icon
264
Estee Lauder
EL
$30.7B
$3.38M 0.09%
23,277
-2,252
-9% -$313K
VBK icon
265
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.2B
$3.36M 0.09%
17,931
+183
+1% +$33.6K
ABEV icon
266
Ambev
ABEV
$48.2B
$3.36M 0.09%
734,468
+27,160
+4% +$129K
MNDT
267
DELISTED
Mandiant, Inc. Common Stock
MNDT
$3.34M 0.08%
196,211
-41,761
-18% -$668K
CLB icon
268
Core Laboratories
CLB
$477M
$3.33M 0.08%
28,727
RHP icon
269
Ryman Hospitality Properties
RHP
$8.41B
$3.3M 0.08%
38,317
+407
+1% +$34.8K
REGN icon
270
Regeneron Pharmaceuticals
REGN
$76B
$3.29M 0.08%
8,150
-100
-1% -$38.1K
VO icon
271
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$3.25M 0.08%
79,212
+2,012
+3% +$82.1K
NLY icon
272
Annaly Capital Management
NLY
$17.4B
$3.24M 0.08%
79,186
+517
+0.7% +$21.7K
SO icon
273
Southern Company
SO
$109B
$3.22M 0.08%
73,934
+8,447
+13% +$389K
AMD icon
274
Advanced Micro Devices
AMD
$791B
$3.22M 0.08%
104,291
+23,428
+29% +$529K
TRV icon
275
Travelers Companies
TRV
$78.4B
$3.17M 0.08%
24,450
+781
+3% +$101K

Similar funds

Oppenheimer & Co's Q3 2018 Portfolio in Review

As of Q3 2018, Oppenheimer & Co held 1,432 positions worth $3.93B, up 6.6% from $3.68B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2018 filing shows 108 new, 538 increased, 575 reduced and 84 closed positions. Its largest new stake was Invesco DB Commodity Index Tracking Fund: 113,354 shares worth $2.04M. The largest sale was A V Homes, Inc., an estimated $12.7M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q3 2018 buy was Invesco DB Commodity Index Tracking Fund: 113,354 shares worth $2.04M.
  • Oppenheimer & Co added most to Meta Platforms (Facebook) in Q3 2018, an estimated $7.62M increase.
  • Oppenheimer & Co's biggest Q3 2018 reduction was Wabtec, cutting an estimated $4.88M.
  • Oppenheimer & Co fully exited A V Homes, Inc. in Q3 2018, selling an estimated $12.7M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.93B portfolio in Q3 2018.
  • Oppenheimer & Co opened 108 new positions and closed 84 in Q3 2018.
  • Oppenheimer & Co's portfolio value rose 6.6% quarter-over-quarter to $3.93B.

Based on Oppenheimer & Co's 13F filing for Q3 2018, filed 26 Oct 2018.